ketoconazole has been researched along with Short Bowel Syndrome in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Short Bowel Syndrome: A malabsorption syndrome resulting from extensive operative resection of the SMALL INTESTINE, the absorptive region of the GASTROINTESTINAL TRACT.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sano, N | 1 |
| Nio, M | 1 |
| Ishii, T | 1 |
| Amae, S | 1 |
| Wada, M | 1 |
| Nishi, K | 1 |
| Endo, N | 1 |
| Hayashi, Y | 1 |
| Ohi, R | 1 |
1 other study available for ketoconazole and Short Bowel Syndrome
| Article | Year |
|---|---|
Oral FK 506 blood levels are elevated in pig short bowel model: further investigations with co-administration of an intestinal CYP3A4 inhibitor.
Topics: Administration, Oral; Anastomosis, Surgical; Animals; Area Under Curve; Cytochrome P-450 CYP3A; Cyto | 2002 |